Supplementary Figure S1 from Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine - O'Connell, Casey L.; Baer, Maria R.; Ørskov, Andreas Due; Saini, Sunil Kumar; Duong, Vu H.; Kropf, Patricia; Hansen, Jakob Werner; Tsao-Wei, Denice; Jang, Hyo Sik; Emadi, Ashkan; Holmberg-Thyden, Staffan; Cowland, Jack; et al. (2023)